Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis

被引:31
|
作者
Paulke-Korinek, Maria [1 ,2 ]
Kollaritsch, Herwig [1 ]
Kundi, Michael [3 ]
Zwazl, Ines [1 ]
Seidl-Friedrich, Claudia [1 ]
Jelinek, Tomas [4 ]
机构
[1] Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, A-1090 Vienna, Austria
[2] Fed Minist Hlth, Vienna, Austria
[3] Med Univ Vienna, Ctr Publ Hlth, Inst Environm Hlth, A-1090 Vienna, Austria
[4] Berlin Ctr Travel & Trop Med, Berlin, Germany
关键词
Japanese encephalitis vaccine; Long-term protection; Low responder; IMMUNITY; CELLS; TBE;
D O I
10.1016/j.vaccine.2015.05.037
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Japanese Encephalitis (JE) virus occurs in wide regions of Asia with over 3 billion people living in areas at risk for JE. An estimated 68,000 clinical cases of JE occur every year, and vaccination is the most effective prophylactic measure. One internationally licensed vaccine containing the inactivated JE virus strain SA(14)-14-2 is lxiaro (R) (Valneva, Austria). According to recommendations, basic immunization consists of vaccinations on day 0, day 28, and a booster dose 12-24 months later. Protection in terms of neutralizing antibody titers has been assessed up to 12 months after the third dose of the vaccine. The current investigation was designed to evaluate antibody decline over time and to predict long-term duration of seroprotection after a booster dose. Method: In a preceding trial, volunteers received basic immunization (day 0, day 28) and one booster dose against JE 15 months later. A follow up blood draw 6 years following their booster dose was carried out in 67 subjects. For antibody testing, a 50% plaque reduction neutralization test (PRNT50-test) was used. PRNT50 values of 10 and above are surrogate levels of protection according to WHO standards. Result: Seventy-six months following the booster dose, 96% of the tested subjects had PRNT50 titers of 10 or higher. Geometric mean titer (GMT) was 148 (95% CI confidence interval: 107-207). Antibody titers were lower in volunteers 50 years of age and older. Vaccination history against other flaviviruses (yellow fever or tick borne encephalitis) did not significantly influence PRNT50 titers. A two-step log-linear decline model predicted protection against JE of approximately 14 years after the booster dose. Conclusion: Six years after a booster dose against JE, long-term protection could be demonstrated. According to our results, further booster doses should be scheduled 10 years following the first booster dose. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3600 / 3604
页数:5
相关论文
共 50 条
  • [21] A case of sudden death after Japanese encephalitis vaccination
    Bunai, Yasuo
    Ishii, Akira
    Akaza, Kayoko
    Nagai, Atsushi
    Nishida, Naoki
    Yamaguchi, Seiji
    LEGAL MEDICINE, 2015, 17 (04) : 279 - 282
  • [22] Hepatitis B vaccine and the need for a booster dose after primary vaccination
    Pileggi, Claudia
    Papadopoli, Rosa
    Bianco, Aida
    Pavia, Maria
    VACCINE, 2017, 35 (46) : 6302 - 6307
  • [23] Duration of neutralizing antibody titer after Japanese encephalitis vaccination
    Abe, Motoharu
    Okada, Kenji
    Hayashida, Kenshi
    Matsuo, Fujio
    Shiosaki, Kouichi
    Miyazaki, Chiaki
    Ueda, Kohji
    Kino, Yoichiro
    MICROBIOLOGY AND IMMUNOLOGY, 2007, 51 (06) : 609 - 616
  • [24] Booster vaccinations against tick-borne encephalitis: 6 Years follow-up indicates long-term protection
    Paulke-Korinek, Maria
    Rendi-Wagner, Pamela
    Kundi, Michael
    Laaber, Brigitte
    Wiedermann, Ursula
    Kollaritsch, Herwig
    VACCINE, 2009, 27 (50) : 7027 - 7030
  • [25] The effects of booster vaccination of hepatitis B vaccine on anti-HBs negative children 11-15 years after primary vaccination
    Yao, Jun
    Ren, Jingjing
    Shen, Lingzhi
    Chen, Yongdi
    Liang, Xiaofeng
    Cui, Fuqiang
    Li, Qian
    Jiang, Zhenggang
    Wang, Fuzhen
    HUMAN VACCINES, 2011, 7 (10): : 1055 - 1059
  • [26] Requirement of a Booster Dose of Hepatitis B Vaccine in Children With Thalassemia After 5 Years of Primary Vaccination: A Prospective Study
    Gomber, Sunil
    Yadav, Ravinder
    Dewan, Pooja
    Ramachandran, V. G.
    Puri, A. S.
    INDIAN PEDIATRICS, 2021, 58 (03) : 237 - 240
  • [27] Enhanced protection against FMDV in cattle after prime- boost vaccination based on mucosal and inactivated FMD vaccine
    Khalifa, Manar E.
    El-Deeb, Ayman H.
    Zeidan, Sayed M.
    Hussein, Hussein A.
    Abu-El-Naga, Hany I.
    VETERINARY MICROBIOLOGY, 2017, 210 : 1 - 7
  • [28] Tick-borne encephalitis after vaccination Vaccine failure or misdiagnosis
    Grgic-Vitek, Marta
    Avsic-Zupanc, Tatjana
    Klavs, Irena
    VACCINE, 2010, 28 (46) : 7396 - 7400
  • [29] Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination
    Comunale, Brittany A.
    Larson, Robin J.
    Hsu, Yea-Jen
    Jackson-Ward, Erin
    Azodoh, Chisom
    Singh, Aditi
    Engineer, Lilly D.
    VACCINES, 2024, 12 (03)
  • [30] Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen vaccines
    Pitisuttithum, Punnee
    Dhitavat, Jittima
    Sirivichayakul, Chukiat
    Pitisuthitham, Arom
    Sabmee, Yupa
    Chinwangso, Pailinrut
    Kerdsomboon, Chawanee
    Fortuna, Librada
    Spiegel, Jane
    Chauhan, Mukesh
    Poredi, Indrajeet Kumar
    van den Biggelaar, Anita H. J.
    Wijagkanalan, Wassana
    Viviani, Simonetta
    Mansouri, Souad
    Pham, Hong Thai
    ECLINICALMEDICINE, 2021, 37